SATS 2009 Final Program - Scandinavian Association for Thoracic ...

Recommendations

Info

S01 SATS AWARD NOMINEES ORAL ABSTRACT SESSION S01:1 IMPACT OF PAPILLARY MUSCLE RELOCATION AS ADJUNCT PROCEDURE TO MITRAL RING ANNULOPLASTY IN FUNCTIONAL ISCHEMIC MITRAL REGURGITATION Jensen Henrik 1 , Jensen Morten 2 , Smerup Morten 3 , Wierup Per 3 , Ringgaard Steffen 4 , Hasenkam J. Michael 3 , Nielsen Sten Lyager 3 1) Aarhus University Hosptital, Skejby, 2) Aarhus Univ. Dept. of Biomed. Eng., 3) Aarhus University Hospital, Skejby, 4) Aarhus Univ. Hosp., MRI-Research Centre, Denmark Background The optimal surgical treatment in functional ischemic mitral regurgitation(FIMR) remains controversial. Recently, a posterior papillary muscle relocation(PMR) technique as adjunct procedure to ring annuloplasty has been proposed to prevent recurrent FIMR. In the present study we used 3D cardiac magnetic resonance imaging to assess the impact of relocating both papillary muscles as adjunct procedure to down-sized ring annuloplasty on mitral leaflet coaptation geometry in FIMR pigs. Methods Eleven FIMR pigs were randomized to down-sized ring annuloplasty(RA, n= 6) or RA combined with PMR(RA+PMR, n=5). In the RA+PMR group a 2-0 Gore-tex suture was attached to each trigone, exteriorized through the corresponding papillary muscle, mounted on an epicardial pad and tightened to relocate the myocardium adjacent to the anterior and posterior papillary muscles 5 and 15 mm, respectively. Using 3D magnetic resonance imaging the impact from these interventions on leaflet geometry was assessed. Results Following statistically significant(p
S01:3 30-DAY OUTCOMES IN HIGH RISK-PATIENTS RANDOMIZED TO OFF-PUMP OR ON-PUMP CORONARY BYPASS SURGERY Møller Christian H 1 , Perko Mario 1 , Lund Jens 1 , Andersen Lars W. 1 , Madsen Jan K. 2 , Gluud Christian 1 , Steinbrüchel Daniel A 1 1) Rigshospitalet, 2) Gentofte Hospital, Denmark Background Coronary artery bypass grafting (CABG) performed with (on-pump) and without (off-pump) cardiopulmonary bypass seems safe and results in about the same outcome in low-risk patients. Observational studies indicate that off-pump surgery may provide more benefit in high-risk patients. Our objective was to compare outcomes in high-risk patients randomized to CABG with or without cardiopulmonary bypass. Methods and Results We randomly assigned 341 patients with a EuroSCORE ≥ 5 and 3-vessel coronary disease to undergo on-pump versus off-pump CABG. Patients were followed up through the Danish National Patient Registry. The primary outcome was a composite of adverse cardiac and cerebrovascular events (i.e., all-cause mortality, acute myocardial infarction, cardiac arrest with successful resuscitation, low cardiac output syndrome/cardiogenic shock, stroke, and coronary reintervention). An independent event committee blinded for treatment allocation assessed the outcomes. Baseline characteristics were well balanced between groups, and the mean number of grafts per patient did not differ significantly between groups (3.22 in off-pump and 3.34 in on-pump, P = 0.11). No significant difference in the composite primary outcome (15% vs 17%, P = 0.48) or the individually components were found at 30-day follow-up. Fewer grafts were performed to the lateral part of the left ventricle territory during off-pump surgery (0.97 vs 1.14 after on-pump surgery; P = 0.01). Conclusion - Both off- and on-pump CABG can be performed in high-risk patients with low short-term complications. Off-pump surgery seems to be associated with a reduced number of grafts to the lateral territory of the left ventricle. S01:4 CATHETER BASED AORTIC VALVE IMPLANTATION – RESULTS FROM THE FIRST 50 PATIENTS Nielsen Hans Henrik Møller 1 , Thuesen Leif 1 , Andersen Henning Rud 1 , Hjortdal Vibeke E 1 , Klaaborg Kaj-Erik 1 , Jakobsen Carl-Johan 1 , Böing Ingeborg 1 1) Aarhus University Hospital, Skejby, Denmark Background Aortic valve stenosis is a common cause of morbidity and mortality among the elderly population. Medical treatment is often inadequate and most patients ultimately need aortic valve surgery (AVS). Up to one third of patients requiring AVS is deemed inoperable due to co-morbidities and consequently high risk. At Aarhus University Hospital, Skejby, catheter based stentvalve implantation have been used to treat selected highrisk patients with aortic valve stenosis since 2006. Aim The aim of this study was to evaluate morbidity and mortality following catheter based aortic valve implantation. Materials and methods: A total of 50 patients were treated with an aortic stentvalve between february 2008 and february 2009. 15 were done via transfemoral (TFA-AVI) technique and 35 via transapical technique (TAP-AVI). Median age of the patients was 83+ 6, 7 and 62% females. Mean logistic EUROscore was 19, 7% and 17, 5% in the TAP-AVI and TFA-AVI group respectively. Results Successful stent valve implantation were performed in 46/50 (92%) patients. The first two patients in this series died during procedure TFA-AVI. There were no peroperative deaths in the TAP-AVI group. 30 days mortality rate was 20% in TFA-AVI and 6% in TAP-AVI group. There was no incidence of peroperative MI or coronary occlusion requiring PCI/CABG. Conclusion Catheter based aortic stent valve implantation is a feasible technique, requiring close co-operation between surgeons, cardiologists and anesthesiologists. The procedure should be reserved for selected highrisk patients deemed inoperable to conventional surgery, until further studies, preferably randomized trials, have documented the technique. STOCKHOLM, SWEDEN 39
Page 1 and 2: Final Programme & Abstracts First J
Page 3 and 4: Table of contents Awards. . . . . .
Page 5 and 6: Transcatheter Valve CardioVascular.
Page 7 and 8: Programme overview Thursday, 20 Aug
Page 9 and 10: Saturday, 22 August 2009 SATS SCANS
Page 11 and 12: Scientific Programme THURSDAY, 20 A
Page 13 and 14: FRIDAY, 21 AUGUST 2009 08:30 - 10:3
Page 15 and 16: FRIDAY, 21 AUGUST 2009 11:00 - 11:3
Page 17 and 18: SATURDAY, 22 AUGUST 2009 08:30 - 10
Page 19 and 20: Cardiac lesions that work Cardiobla
Page 21 and 22: Introducing... V-Loc Advanced Woun
Page 23 and 24: Smoking policy Kistamässan and the
Page 25 and 26: ��
Page 27 and 28: Kistamässan Overview KONFERENS Fir
Page 29 and 30: M2 M1 Exhibition Floor Plan STOCKHO
Page 31 and 32: Authors' Index A Aasmundstad, Tor S
Page 33 and 34: R Raffa, Giuseppe S05:5 Raoul, Berg
Page 36 and 37: Epic Stented Tissue Valve with Lin
Page 40 and 41: S01:5 THE NEW TNM STAGING SYSTEM FO
Page 42 and 43: S03:3 GABAPENTIN FOR POSTOPERATIVE
Page 44 and 45: S05 SATS CARDIAC ORAL ABSTRACT SESS
Page 46 and 47: S05:5 MINIMALLY INVASIVE REOPERATIV
Page 48 and 49: S06 SCANSECT ORAL ABSTRACT SESSION
Page 50 and 51: S06:4 IN VITRO COMPARISON OF THE NE
Page 52 and 53: S06:8 COAGULATION IN OXYGENATOR AND
Page 54 and 55: S07:3 SURGICAL TEAM MEMBER’S EXPE
Page 56 and 57: S07:7 ADDRESSING THE SPOUSES UNIQUE
Page 58 and 59: S09:3 THE NO TOUCH VEIN GRAFT HARVE
Page 60 and 61: S09:7 SURGICAL CORRECTION OF PECTUS
Page 62 and 63: S10:3 VALIDATION OF CYSTATIN C WITH
Page 64 and 65: S18 PHYSIOTHERAPISTS ORAL ABSTRACT
Page 66 and 67: P01 POSTER SESSION P01:01 PLATELET
Page 68 and 69: P01:04 RIGHT VENTRICULAR 3-D ARCHIT
Page 70 and 71: P01:08 THE EFFECT OF CO2-INSUFFLATI
Page 72 and 73: P01:12 REOPERATION FOR BLEEDING FOL
Page 74 and 75: P01:16 PNEUMONECTOMY FOR NON-SMALL
Page 76 and 77: P01:20 SURGICAL REVASCULARIZATION A
Page 78 and 79: P01:24 HOW DOES INTRAOPERATIVE ASSE
Page 80 and 81: P01:28 CORONARY ARTERY BYPASS GRAFT
Page 82 and 83: P01:32 RECIPIENT CELLS IN BRONCHIAL
Page 84 and 85: P01:36 ACUTE DYSFUNCTION OF MECHANI
Page 86 and 87: P01:40 SVO2 A MARKER WITH EXCELLENT
Page 88 and 89:
P01:44 SUBCLAVIAN ARTERY APPROACH I
Page 90 and 91:
P01:48 NURSING STUDY 30 DAYS AFTER
Page 92 and 93:
Notes www.sats2009.org
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100:
www.sats2009.org
show all

SATS 2009 Final Program - Scandinavian Association for Thoracic ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?